全文获取类型
收费全文 | 27055篇 |
免费 | 2709篇 |
国内免费 | 592篇 |
专业分类
耳鼻咽喉 | 138篇 |
儿科学 | 1031篇 |
妇产科学 | 801篇 |
基础医学 | 640篇 |
口腔科学 | 179篇 |
临床医学 | 1955篇 |
内科学 | 2467篇 |
皮肤病学 | 144篇 |
神经病学 | 192篇 |
特种医学 | 531篇 |
外国民族医学 | 64篇 |
外科学 | 2829篇 |
综合类 | 3245篇 |
现状与发展 | 2篇 |
预防医学 | 555篇 |
眼科学 | 101篇 |
药学 | 2178篇 |
19篇 | |
中国医学 | 804篇 |
肿瘤学 | 12481篇 |
出版年
2024年 | 63篇 |
2023年 | 369篇 |
2022年 | 846篇 |
2021年 | 1142篇 |
2020年 | 980篇 |
2019年 | 860篇 |
2018年 | 880篇 |
2017年 | 976篇 |
2016年 | 1208篇 |
2015年 | 1131篇 |
2014年 | 1681篇 |
2013年 | 2164篇 |
2012年 | 1491篇 |
2011年 | 1723篇 |
2010年 | 1321篇 |
2009年 | 1355篇 |
2008年 | 1317篇 |
2007年 | 1468篇 |
2006年 | 1310篇 |
2005年 | 1096篇 |
2004年 | 882篇 |
2003年 | 800篇 |
2002年 | 704篇 |
2001年 | 635篇 |
2000年 | 520篇 |
1999年 | 496篇 |
1998年 | 391篇 |
1997年 | 398篇 |
1996年 | 286篇 |
1995年 | 264篇 |
1994年 | 253篇 |
1993年 | 168篇 |
1992年 | 139篇 |
1991年 | 135篇 |
1990年 | 109篇 |
1989年 | 100篇 |
1988年 | 86篇 |
1987年 | 76篇 |
1986年 | 62篇 |
1985年 | 78篇 |
1984年 | 70篇 |
1983年 | 60篇 |
1982年 | 41篇 |
1981年 | 45篇 |
1980年 | 41篇 |
1979年 | 34篇 |
1978年 | 34篇 |
1977年 | 26篇 |
1976年 | 27篇 |
1975年 | 10篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
支气管动脉灌注化疗联合直线加速器放射治疗Ⅲa期非小细胞肺癌 总被引:1,自引:1,他引:0
目的 研究支气管动脉灌注化疗联合直线加速器放射治疗Ⅲa期非小细胞肺癌 (NSCLC)的可行性及临床价值。方法 76例NSCLC患者随机分成A、B 2组 ,A组先行 2次支气管动脉灌注化疗 (BAI) ,第 2次BAI 1~ 2周后再行直线加速器放射治疗 (RT) ;B组单纯行 2次BAI (对照组 )。结果 临床疗效 ,A组 (BAI RT)和B组 (BAI)分别为 89.47%和 60 .5 3% (Ρ <0 .0 1) ;1、3年生存率 ,A、B组分别为 81.5 8%、5 0 .0 0 %和 60 .5 3%、2 1.0 5 % ( 0 .0 1<Ρ <0 .0 5 )。结论 支气管动脉灌注化疗联合直线加速器放射治疗Ⅲa期非小细胞肺癌的临床疗效和患者 1、3年生存率均显著提高 相似文献
52.
成人ANLL初治患者61例用HA方案和DA方案治疗的效果相似(包括CR率,中位缓解时间),而HA方案的心脏毒性及并发严重感染率均较DA方案少见和轻微(P<0.01)。成人ANLL140例用VMP或VDP方案治疗的效果相仿,而VMP方案治疗骨髓抑制率及并发严重感染率较少见和轻微(P<0.05)。结果表明,HA或VMP方案对白血病细胞均有明显的杀伤,可以分别替代DA和VDP方案,具有实用价值;HA和H 相似文献
53.
目的 分析孕激素联合以铂类为主的常规化疗对卵巢上皮性癌1~4期患者的临床疗效。方法 以已行瘤体减灭术的卵巢上皮性癌患者1~4期为研究对象,分为单纯化疗组、己酸孕酮组和普维拉组。随访、统计各组各期患者的生存率及复发率、血清激素水平、骨密度变化以及化疗副反应。结果 孕激素联合以铂类为主的化疗对早期卵巢上皮性癌的预后无明显影响,但对晚期(3期)卵巢上皮性癌的术后近期以及远期(2~5年)生存率及复发率均有改善趋势。单纯化疗组、己酸孕酮组、普维拉组3期患者术后3年生存率分别为34.8%、66.2%、73.9%,复发率分别为72.2%、47.3%、40.6%;单纯化疗组、己酸孕酮组术后5年生存率分别为17.4%、48.4%,复发率分别为81.5%、62.4%。孕激素的使用不影响患者血清激素水平,也不增加化疗的毒、副作用。联合孕激素治疗的患者术后骨密度下降较一般绝经后妇女慢。结论 孕激素联合以铂类为主的常规化疗可改善晚期卵巢上皮性癌的预后,并且不增加化疗的毒副作用,可改善患者的骨量丢失。 相似文献
54.
目的探索调强放射治疗 (IMRT)提高进展期胰腺癌局部肿瘤靶区剂量以及减少周围正常组织照射剂量的可能性。 方法 2 1例局部进展期胰腺癌患者接受同期放化疗。放射治疗分第一阶段予常规放射治疗 ,剂量30Gy/ 15次 / 3周 ;第二阶段强调放射治疗 ,肿瘤靶区分割剂量 3Gy/次 ,总剂量为 2 1~30Gy ,在 2周内分 7~10次完成。总剂量递增水平 :5 1、5 4、5 7、6 0Gy。在放射治疗过程中 ,每个治疗日 5 -FU静脉点滴。 结果 16例完成治疗计划 ,分别为 5 1Gy 3例、5 4Gy 3例、5 7Gy 3例 ,6 0Gy 7例。 13例治疗前CA19- 9值升高 ,中位值治疗前后分别为 716、2 5 5U/ml(P <0 .0 0 1)。 14例以疼痛为主的患者至少减少 1/ 3~1/ 2的麻醉药品用量 ,其中 5例疼痛症状完全消失。10例患者治疗后卡氏评分有提高。 结论局部进展期胰腺癌患者接受适形调强放疗并同期应用 5 -Fu化疗增敏 ,可获得确切的姑息治疗作用 ,肿瘤剂量 6 0Gy分 2 5次在 5周完成 ,无严重的放射治疗相关的急性毒性反应 相似文献
55.
Kazumasa Fujitani Jaffer A. Ajani Christopher H. Crane Barry W. Feig Peter W. Pisters Nora Janjan Garrett L. Walsh Stephen G. Swisher Ara A. Vaporciyan David Rice Angela Welch Jackie Baker Josephine Faust Paul F. Mansfield MD 《Annals of surgical oncology》2007,14(4):1305-1311
Background Significant tumor downstaging has been achieved in patients with localized gastric or gastroesophageal adenocarcinoma by induction
chemotherapy and preoperative chemoradiotherapy (CTX–CTXRT). However, the influence of CTX–CTXRT on operative morbidity and
mortality has not yet been clarified. The aim of the present study was to document the frequency and nature of morbidity and
mortality after surgery combined with CTX–CTXRT, and identify factors predictive of postoperative complications in patients
with localized gastric or gastroesophageal adenocarcinoma.
Methods A prospectively collected database on 71 consecutive patients who underwent CTX–CTXRT at M.D. Anderson Cancer Center between
January 1997 and August 2004 was reviewed. Postoperative morbidity and mortality were investigated, and risk factors for overall
complications were identified by multivariate logistic regression analysis.
Results Overall morbidity and mortality rates were 38.0% (27 patients) and 2.8% (2 patients), respectively. Age greater than 60 years
[relative risk 11.3 (95% confidence interval 2.50–50.6)] and body mass index (BMI) of 26 kg/m2 or above [relative risk 4.08 (95% confidence interval 1.08–15.4)] were significant risk factors for overall complications.
Conclusions CTX–CTXRT can be performed safely with an acceptable operative morbidity and a low operative mortality rate in patients with
gastric or gastroesophageal cancer, with careful consideration of added risk associated with age and obesity. 相似文献
56.
Jun Maeda Mitsunori Ohta Hirohisa Hirabayashi Hikaru Matsuda 《The Japanese Journal of Thoracic and Cardiovascular Surgery》2005,53(4):196-198
We present a case of lung cancer that showed false positive accumulation in an 18F fluorodeoxyglucose positron emission tomography (FDG-PET) scan following induction chemotherapy for suspected metastasis
and progression of malignancy. A 66-year-old man was diagnosed with squamous cell carcinoma in the lung, classified as clinical
stage IIIA (T2N2M0), and underwent induction chemotherapy. An FDG-PET scan prior to chemotherapy demonstrated accumulation
only in the tumor, whereas following treatment it revealed a strong accumulation not only in the tumor, but also in the supraclavicular
lymph nodes, which indicated lymph node metastasis. The patient underwent a biopsy of the right supraclavicular lymph node
and mediastinoscopy, after which all dissected lymph nodes showed sarcoid reactions and no tumor cells were found pathologically.
We concluded that when evaluating the effect of induction chemotherapy for malignancy, a sarcoid reaction might lead to the
false positive accumulation of FDG. 相似文献
57.
化疗药物性静脉炎及渗漏损伤的动物实验模型是研究体内化疗药物性静脉炎及渗漏损伤的发病机制和评价各种治疗方法的重要条件。化疗药物性静脉炎及渗漏损伤的实验研究进展缓慢,其主要原因是缺乏理想的动物模型。依文献报道,化疗药物性静脉炎模型主要以大白兔耳缘静脉注射长春瑞滨等化疗药物为多见,化疗药物渗漏损伤模型主要以大鼠及大白兔背部皮下注射盐酸阿霉素等化疗药物为多见。文章就近年来常用的一些化疗药物性静脉炎及渗漏损伤的动物模型综述如下。 相似文献
58.
Auke J. S. Renard Ren P. H. Veth Maciej Pruszczynksi Jaap Hoogenhout Jos Bkkerink Frans J. M. Van Der Staak Theo Wobbes Josef A. M. Lemmens Ren van Hoesel Jim R. Van Horn 《Journal of surgical oncology》1995,60(4):250-256
This paper describes 29 patients with Ewing's sarcoma of bone treated between 1975 and 1990 at the University of Nijmegen Hospital, Nijmegen, The Netherlands. Osteomyelitis was the primary diagnosis in 24%. Treatment consisted of chemotherapy in combination with surgery and/or radiotherapy. Nine patients received radiotherapy only; five of them died of disease. Five patients underwent an intralesional excision; four of them died of disease. Twelve patients underwent a wide excision; there is no evidence of disease in any of them. Three patients underwent a radical disarticulation; all died of disease. The disease-free survival at 1.5 years was 66%. This figure at 5 years was 55%. After wide excision and reconstruction in tumors of expendable, femoral or radial bones good functional results were obtained in all cases. © 1995 Wiley-Liss, Inc. 相似文献
59.
60.
Isao Kurosaki Kazuhiro Tsukada Hidenori Ueki Akira Ohya Katsuyoshi Hatakeyama 《Journal of Hepato-Biliary-Pancreatic Surgery》1997,4(1):131-134
We report a case of advanced gallbladder cancer in a 37-year-old man who presented in June 1993 with malignant obstructive jaundice. After percutaneous transhepatic biliary drainage and several diagnostic imaging examinations, the patient underwent laparotomy under a diagnosis of extremely advanced gallbladder cancer involving the confluence of the hepatic ducts. The tumor, however, was judged to be unresectable because of its massive spread into the liver along Glisson's sheath, and because of histologically proven peritoneal dissemination. After exploratory laparotomy, one course of anticancer chemotherapy (cisplatin, 100 mg/body IV, on day 1, and 5-fluorouracil, 1000 mg/body, on days 1–5, by continuous infusion) was administered and the completely obstructed hepatic duct was dramatically re-canalized. Four courses of chemotherapy were administered over a 16-month period until jaundice recurred. For these 16 months, the patient's quality of life was well maintained without biliary drainage. He died of increased peritoneal dissemination approximately 2 years after the first course of anticancer chemotherapy. 相似文献